Ampiginous chorioretinopathy associated with T-cell lymphoma
Purpose
To report a case of ampiginous chorioretinopathy (AMP) in a patient with T-cell lymphoma
Methods
Case Report
Results
A 38-year-old male patient with T-cell lymphoma and history of brain micro-hemorrhages reported decreased best corrected visual acuity (BCVA) in his right eye (RE). BCVA RE was 20/100 and left eye (LE) 20/20. RE showed subfoveal choroidal neovascularization (CNV), choroidal infiltrates, venous sheathing and vitreous opacities. A complete panel was negative for syphilis, TB and toxo. Treatment with bevacizumab and trans-Tenon triamcinolone was performed during two years with BCVA gain (20/50) and resolution of CNV. Cataract surgery was performed with further BCVA gain (RE 20/30, LE 20/20).
The patient was lost to follow-up and returned 7 years later reporting decreased bilateral BCVA (RE counting fingers, LE 20/50). Ocular exam showed no sign of anterior chamber or vitreous infiltration. Fundus revealed RE perivascular and peripapillary retinal atrophy and was normal for the LE.
Fundus autofluorescence (FAF) confirmed RE confluent atrophic foci and hyper autofluorescence macular areas. OCT revealed complete RE macular atrophy and LE subfoveal neurosensory detachment.
Fluorescein angiography showed RE extramacular foci of fluorescein leakage and LE macular edema with no signs of CNV.
A new blood panel revealed no significant results and clinical diagnosis of AMP was made. Systemic steroidal therapy was started followed by intravitreal injection of a dexamethasone implant with mild LE visual improvement (20/25) and resolution of subfoveal fluid.
Conclusion
Concurrence of AMP and neurological disease has been reported,. To our knowledge, this is the first case of concurrence of AMP with a T cell lymphoma.
Conflict of interest
No
Authors 1
Last name
MONTERO-MORENO
Initials of first name(s)
J
Department
Ophthalmology. Rio Hortega Hospital
City
Valladolid
Country
Spain
Authors 2
Last name
Diez-Montero
Initials of first name(s)
C
Department
Ophthalmology. Rio Hortega Hospital
City
Valladolid
Country
Spain
Authors 3
Last name
Sanchis-Merino
Initials of first name(s)
ME
Department
Ophthalmology Clinical Trials Unit. Rio Hortega Hospital
City
Valladolid
Country
Spain
Authors 4
Last name
Gonzalez-Urueña
Initials of first name(s)
C
Department
Ophthalmology Clinical Trials Unit. Rio Hortega Hospital
City
Valladolid
Country
Spain
Authors 5
Last name
Hernandez-Fernandez
Initials of first name(s)
R
Department
Ophthalmology Clinical Trials Unit. Rio Hortega Hospital
City
Valladolid
Country
Spain
Authors 6
Last name
Cañibano-Perez
Initials of first name(s)
E
Department
Ophthalmology Clinical Trials Unit. Rio Hortega Hospital
City
Valladolid
Country
Spain
This website uses cookies to ensure you get the best experience on our website.
Learn more